background: Most trophoblast cell lines currently available to study vertical transmission of hepatitis B virus (HBV) are immortalized by viral transformation. Our goal was to establish and characterize a spontaneously immortalized human first-trimester trophoblast cell line and its HBV-expressing clone.
Introduction
The human placenta is made up of chorionic villi comprising the fetal capillary, villous stroma and a layer of trophoblast cells, consisting of syncytiotrophoblasts and cytotrophoblasts. Placental trophoblasts play a crucial role during embryonic implantation, and the high permeability of undifferentiated trophoblasts to viral transfer makes early pregnancy a highly susceptible period for intrauterine infections (Bhat and Anderson, 2007) .
Hepatitis caused by the hepatitis B virus (HBV) is a leading cause of death worldwide and is highly endemic in Africa and Asia. About 2 billion people have been infected with HBV to date, and over 350 million people are carriers of HBV surface antigen (HBsAg). Chronic hepatitis, cirrhosis and hepatocellular carcinoma caused by HBV are responsible for 500 000 to 1.2 million deaths every year (Lavanchy, 2004) . The most common route of HBV transmission is via the perinatal or intrauterine routes. It has been reported that 10-15% of pregnant women in China are carriers of HBsAg and HBV e antigen (HBeAg) and 5-15% of these babies are infected by intrauterine transmission (Li et al., 1986; Xu et al., 2002; Zhang et al., 2004) . Asian women are predominantly infected with the adr subtype of HBV. † These three authors contributed equally to this article.
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Although the exact mechanism of intrauterine HBV infection is not completely understood, transplacental leakage of maternal blood has been suggested as a possible mechanism Ohto et al., 1987) . We previously hypothesized that 'cellular transfer' of HBV from cell to cell in the placenta may also contribute to intrauterine infection (Xu et al., 2001 . Since placental trophoblasts gate the maternal-fetal interface, they may play a crucial role in the placental invasion of HBV and are reported to be susceptible to HBV infection (Xu et al., 2001 .
A major challenge in the biological and pathogenetic study of HBV has been the difficulty of culturing the highly specific host cells (Feitelson, 1994) . HBV-infected host cells usually contain free and replicationcompetent HBV at the early stages of infection and the virus integrates into the host genome after a few passages. However, it has been suggested that HBV DNA does not integrate into the trophoblast genome, since the viral DNA does not continue to replicate with the proliferation of trophoblasts (Wang et al., 2006a,b) .
A number of groups have established trophoblast cell lines for in vitro experimentation. These cell lines are all either immortalized by viral transformation or arise from cancerous villi or placenta. The HTR-8/SVneo cell line was established by transfection of parental first-trimester human extravillous trophoblast HTR-8 cells with SV40 large T antigen (Graham et al., 1993) . These cells were phenotypically similar to the parental cells and had an extended life span. However, HTR-8 cells transformed with the SV40 T antigen oncogene also gave rise to a long-lived and an immortalized cell line, which both exhibited hyperproliferative, hyperinvasive and premalignant properties (Khoo et al., 1998) . In a different study, first-trimester trophoblast cells generated by SV40 transformation showed karyotypic/phenotypic abnormalities (Straszewski-Chavez et al., 2009) . Normal placentaorigin cytotrophoblast (NPC) cells were developed from firsttrimester human placental villi (Rong-Hao et al., 1996) , which maintained the endocrine functions of normal cytotrophoblasts but achieved replicating senescence after 50 population doublings. Since telomerase activation via overexpression of human telomeric reverse transcriptase is known to circumvent senescence, this strategy was used to overcome senescence in NPC cells to generate an immortalized cytotrophoblast cell line (Wang et al., 2006a,b) . A few other groups have successfully isolated and cultured trophoblasts in recent years, using different strategies (Lewis et al., 1996; King et al., 2000; Shiverick et al., 2001; Morrish et al., 2002; Wang et al., 2002; Dunk et al., 2003) . One such established cell line, TEV-1, was obtained from Asian normal early villi and immortalized by transfection with human papillomavirus type 16 E6/E7 genes (Feng et al., 2005) . TEV-1 cells may therefore not be suitable for the study of intrauterine HBV infection. Our study aimed to generate a spontaneously immortalized, cytotrophoblast cell line from Asian human first-trimester placenta and its HBV-expressing clone. This cell line may facilitate our future investigations into the mechanism of HBV infection in trophoblasts.
Materials and Methods

Cell lines
The human liver carcinoma cell line (HepG2) and JEG-3 choriocarcinoma cells were obtained from the Department of Microbiology, Fourth Military Medical University, Xi'an, China. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Paisley, UK) supplemented with 10% fetal calf serum (FCS) (Gibco), 3000 mg/l L-Glutamax (Gibco), 100 U/ml of penicillin and 100 mg/ml of streptomycin (Gibco) and maintained at 378C in a humidified atmosphere of 5% CO 2
Preparation of human first-trimester trophoblast primary culture HPT-8
Collection of human tissue in this study was performed using protocols approved by the Clinical Research Ethics Approval Committee of the Fourth Military Medical University of China. Informed consent was obtained from all study participants. Human placentae (6-9 weeks after amenorrhea, n ¼ 22) were obtained from women undergoing a legal termination of normal pregnancy at Xijing Hospital, Xi'an, China. Termination of pregnancy was surgically achieved by vacuum suction as approved by the local ethical committee. Pregnancies with medical complications or diseases were excluded. Primary cultures of trophoblasts were prepared using a modification of a previously described method . Briefly, chorionic villi were digested in 0.25% trypsin and 500 U/ml collagenase I (Sigma, St. Louis, MO, USA) at 378C for 15 min. The cell suspension was filtered through 75-mm filters (Zhengxing Biotechnology, Anping, China) and centrifuged at 200g for 10 min. Erythrocytes were removed by treating with 0.84% NH 4 Cl at 48C for 6 min. The final cell suspension was maintained in DMEM supplemented with 10% FCS, 2 mM glutamine, 1.75 mM HEPES (Promega, Madison, WI, USA), 100 U/ml penicillin and 100 mg/ml streptomycin at 378C in a 5% CO 2 humidified atmosphere. We cloned the immortalized cells using limiting dilution technique. Briefly, the cell suspension was limiting diluted to 1 cell/ml and plated 250 ml/well into 96-well plates. The monoclone which developed in a single well (hypothetically one original cell in that well) was isolated and expanded in DMEM supplemented with 10% FCS. The HPT-8 cell line was derived from a single clone which had survived more than 250 passages.
Construction of plasmids and transfection
The plasmids pcDNA3 and pUC19-3HBV were kind gifts from the Department of Biochemistry and Molecular Biology, Fourth Military Medical University and the Institute of Immunology, Shandong University School of Medicine, China, respectively. A fragment containing three head-to-tail repeats of the HBV genome (9600 bp) was released from pUC19-3HBV and cloned into pcDNA3 to create pcDNA3-3HBV, which was confirmed by sequencing. HPT-8 cells, (90% confluent) were transfected with pcDNA3-3HBV at passages 18, 30 and 60, using Lipofectamine (Gibco) according to the manufacturer's instructions. After a 48 h incubation, the cells were selected in culture medium containing 1000 mg/ml G418 (Gibco) for 4 weeks. Single clones (HPT-8-HBV) were isolated and maintained in medium containing 300 mg/ml G418. HepG2 cells were transfected with pcDNA3-3HBV to serve as a positive control. HPT-8 transfected with empty vector served as a negative control.
Scanning and transmission electron microscopy
HPT-8 cells at passages 12, 18 and 32 were plated on coverslips. For scanning electron microscope (SEM), cells were washed with 0.01 M phosphate-buffered saline (PBS, pH 7.4), fixed with 3% glutaraldehyde for 3 h and sequentially treated with a graded series of acetonitrile solutions (50, 70, 90 and 100%) . The cells were then dried under vacuum for 2 h, mounted on aluminum stubs sputter coated with colloidal gold and examined using a Hitachi S-520 SEM (Hitachi, Japan). For transmission electron microscope, HPT-8 cells were collected by trypsinization and centrifuged at 200g for 10 min. Cells were fixed in 3% glutaraldehyde for 3 h and osmic acid for 2 h, and dehydrated in an acetone gradient (50, 70, 90 and 100%) . Cells were then immersed in acetone-epoxy resin solution (1:1) for 0.5 h, and embedded in Epon-812 at 658C for 24 h. Ultrathin (60 nm) sections were stained with uranyl acetate and lead citrate. Cell morphology was measured by a JEOL JEM-2000EX transmission electron microscope (Tokyo, Japan).
Cell cycle analysis by flow cytometry
Passages 5, 20 or 60 HPT-8 cells were cultured in 35-mm dishes for 72 h, trypsinized and centrifuged at 200g for 5 min. The cell pellet was resuspended and fixed in 70% ethanol at 48C overnight, centrifuged at 200g for 10 min and resuspended in 5 ml of cold PBS. The cells were incubated at 378C for 1 h in 1 ml of PBS containing 100 mg/ml RNase A (Invitrogen, Carlsbad, CA, USA) and 50 mg/ml propidium iodide (Sigma), and cell cycle analysis performed using a BECKMAN-COULTER flow cytometer (Miami, FL, USA).
Immunocytochemical and immunofluorescent staining
HPT-8 cells at passages 9, 10, 14, 18, 22, 26, 28, 30, 36, 40, 45, 50, 52, 56, 62, 72, 82 and 88, were grown on coverslips for 48 h, fixed with 95% ethanol for 30 min and blocked with 5% normal human serum for 1 h. Cells were then incubated at 48C overnight with one of the following: mouse anti-human cytokeratin 7 (CK7), rabbit anti-human stromal cellderived factor 1 (SDF1), mouse anti-hCG, rabbit anti-human placental lactogen (hPL), rabbit anti-human a cluster of differentiation antigen 9 (CD9), rabbit anti-human epidermal growth factor receptor (EGFR), mouse antihuman placental alkaline phosphatase (PLAP), mouse anti-human HBsAg or rabbit anti-human hepatitis B core antigen (HBcAg; Sigma) at 1:100 dilution (except anti-PLAP, 1:60 dilution). Cells were then incubated with biotinylated immunoglobulin (Ig) G antibody (Wuhan Boshide, Wuhan, China) at room temperature for 60 min and streptavidin-biotinperoxidase complex (S-ABC, Wuhan Boshide) at 378C for 30 min, and visualized after treating with 3,3 ′ -diaminobenzidine (DAB) solution (Wuhan Boshide) for 10 min. Nuclei were visualized by incubating cells in 5 mg/ml of 4(6-diamidino-2-phenylindole; DAPI) (Sigma). For immunofluorescence, the cells were blocked by incubation with 5% normal human serum for 1 h and then incubated at 378C for 60 min with fluorescein isothiocyanate (FITC)-labeled mouse anti-human cytokeratin 18 (CK18) or Cy3-labeled rabbit anti-human vimentin (1:1) antibodies (Sigma) at 1:150 dilution in 1% bovine serum albumin. Slides were then washed, dehydrated and observed under a confocal immunofluorescent microscope (ZEISS, Jena, Germany). The primary antibody was omitted and substituted with isotype IgG in negative controls. Villous tissue sections were used as positive controls.
Immunohistochemical detection of HLA-G in HPT8 cells
Briefly, HPT-8 cells were grown on coverslips and fixed with 95% ethanol for 30 min. Cells were blocked by incubation with 5% normal human serum for 1 h and then incubated at 48C overnight with a 1:100 dilution of rabbit anti-HLA-G (Beijing Boisynthesis Biotechnology co., China) in 0.01 M PBS (pH 7.4). Cells were washed and sequentially incubated for 60 min at room temperature with biotinylated IgG antibody (Wuhan Boshide) and for 30 min at 378C with S-ABC (Wuhan Boshide). Protein was visualized by incubating cells with DAB solution (Wuhan Boshide) for 10 min. Nuclei were visualized by hematoxylin staining. Immunohistochemical experiments were performed five times to ensure reproducibility.
Flow cytometric analysis
We used flow cytometry to determine HLA-G expression in HPT-8 cells. JEG-3 choriocarcinoma cells and HepG2 cells were used as positive and negative controls, respectively. Non-specific binding of antibodies was blocked by pre-incubating cells in 10% human AB-group serum at 48C for 60 min. After washing with PBS, the cells were incubated with the primary antibody (rabbit anti-HLA-G; Beijing Boisynthesis Biotechnology Co.) for 1 h at 48C. Then cells were washed twice and stained with FITCconjugated goat anti-rabbit IgG (Dako Cytomation, Glostrup, Denmark) for 30 min at 48C. Flow cytometric analysis was performed on a FACStar flow cytometer (Becton Dickinson, Mountain View, CA, USA). The cells were gated using forward and side scatter.
Radioimmunoassay
Passage 12 HPT-8 cells were seeded at a density of 1 × 10 6 cells in a 60-mm dish and cultured for 24 h. The supernatant was collected for the determination of human prolactin, estradiol (E 2 ), progesterone and hCG by radioimmunoassay according to the manufacturer's instructions (Capintec Inc., Ramsey, NJ, USA).
Enzyme-linked immunosorbent assay for the detection of HBsAg and HBeAg
The culture medium from HPT-8-HBV, HepG2-HBV and empty vector transfected HPT-8 cells was collected 72 h after transfection and assayed for the presence of HBsAg and HBeAg using diagnostic ELISA kits (Kehua Biotechnology, Shanghai, China), according to the manufacturer's instructions. Culture medium from untransfected cells was used as a background for the assay.
DNA extraction and PCR
Culture medium from stably transfected HPT-8-HBV and HepG2-HBV cells was centrifuged at 10 000g for 10 min to remove cellular debris. HBV particles were precipitated with polyethylene glycol 8000 (Sigma) as described (Wei et al., 1996) . DNA was extracted from virus pellets, HPT-8-HBV, HepG2-HBV and negative control cells using lysis buffer (0.25% sodium dodecyl sulfate, 0.25 M Tris, 0.25 M EDTA) and used in PCRs. The sequences of primers for HBV, HBV relaxed-circular DNA (rcDNA) and HBV covalently closed circular DNA (cccDNA) were 5 ′ -CACTGCAGCCTG CTCGTGTTACAGGC-3 ′ (sense) and 5 ′ -CGGTC GACGGCACTAGTAAACTGAGC-3 ′ (antisense) with a product of 500 bp, 5
′ -CCGACCACGGGGCGCACCTCTCTTTACG-3 ′ (sense) and 5
′ -CTAATCTCCTCCCCCAGCTCCTCCCAGT-3 ′ (antisense) with a product of 243 bp and 5 ′ -CCGACCACGGGGCGCACCTCTCTT TACG -3 ′ (sense) and 5 ′ -AAGG CACAGCTTGGAGGCTTGAACA GT-3 ′ (antisense) with a product of 373 bp, respectively. All PCR conditions were: initial denaturation at 948C for 5 min, then 35 cycles of 948C for 50 s, 558C for 50 s and 728C for 55 s, followed by a final extension step of 728C for 10 min in a PE 480 PCR system (Perkin-Elmer, Boston, MD, USA). PCR products were separated electrophoretically on a 1% agarose gel stained with ethidium bromide for visualization.
Quantitative fluorescent PCR
Culture medium was collected from HPT-8-HBV and HepG2-HBV cells at 48 h, 1 month or 2 months after transfection. An HBV fluorescent PCR kit (Dalean, Shenzhen, China) was used to quantitate HBV DNA titers. A titer of .1 × 10 6 copies per liter was regarded as positive.
Results
Morphological and karyotype characterization of HPT-8 cells
Of the 22 chorionic villus samples, 20 of the first-trimester human trophoblast primary cultures died after six or seven passages. Two samples developed a clone, which became immortalized and remained alive after 250 passages with 3 or 4 days per passage. The spontaneously immortalized HPT-8 cells, which were derived from a single clone, had 70-90% viability, proliferated rapidly and were microscopically epithelioid. HPT-8 cells formed giant multinucleated cells after aggregation (Fig. 1A) . SEM analysis demonstrated that the cells were flat and plane with an irregular polygonal appearance and a large number of microvilli on the surface (Fig. 1B) . TEM analysis showed that HPT-8 cells were characterized by the presence of a concave nuclear envelope, prominent euchromatin, a big nucleolus and dilated cisternae of endoplasm, a large number of glycogen granules, myeloid bodies and lipid inclusions (Fig. 1C ). There were distinct desmosomes between adjacent cells (Fig. 1D ). Karyotyping analysis showed that passage 5 HPT-8 cells had a normal karyotype of 46,XX (Supplementary data, Fig. S1 ). Immunohistochemical staining showed the expression of HLA-G in HPT-8 cells (Fig. 2) . HLA-G was consistently but weakly expressed in HPT-8 cells.
Flow cytometric analysis confirmed that HLA-G was expressed in 17.39% of the HPT-8 cells in comparison with 61.75% of the JEG-3 cells (positive control) and 0.93% of the HepG2 cells (negative control) (Fig. 3) .
Cell cycle profile of HPT-8 cells
HPT-8 cells at passages 5, 20 and 60 showed no obvious differences in their cell cycle profiles (Fig. 4) . Flow cytometry analysis showed that 58.5% cells were in the G1-phase, 29.8% in the S-phase and 11.7% in the G2-phase.
Expression of cytotrophoblast markers in HPT-8
The phenotypic characterization of placental villi and HPT-8 cells is summarized in Table I . Immunohistochemical staining showed the presence of cytotrophoblast markers, CK7, CD9, SDF1, PLAP and EGFR in the cytoplasm of HPT-8 cells (Fig. 5A) . Immunofluorescent staining showed high levels of CK18 and vimentin in the cytoplasm of HPT-8 cells (Fig. 5B) . Villous tissue was used as a positive control for these markers (data not shown).
Hormone levels in the supernatant of HPT-8 cells by radioimmunoassay
We used radioimmunoassay to analyze hormone levels in passage 12 HPT-8 cells. Twenty-four hours after seeding, the levels of prolactin, E 2 , progesterone and hCG in the supernatant of 80% confluent HPT-8 cells were (mean + SD, n ¼ 3 experiments) 8.97 + 1.05 mg/l, 9.7 + 0.58 ng/l, 0.44 + 0.10 and 1.06 + 0.085 mg/l, respectively.
Characterization of HPT-8-HBV cells
HPT-8 cells and HepG2 cells were transfected with pcDNA3-3HBV (adr subtype) at 30% transfection efficiency. G418 selection medium was used to select stably transfected HPT-8-HBV and HepG2-HBV cells. HPT-8-HBV cells proliferated slowly after passage 4 and most cells died after passage 6. However, HepG2-HBV cells remained healthy even after passage 10 (data not shown), indicating that the integration of HBV into the genome of HPT-8 cells was less efficient than into the highly specific host HepG2 cells. PCR amplification was used to detect the presence of HBV rcDNA and cccDNA in HepG2-HBV and HPT-8-HBV cells at passage 2 (Fig. 6A and B) . Two stably transfected cell lines were strongly positive for the presence of HBV rcDNA and cccDNA, while parental HPT-8 cells were negative. Immunohistochemistry showed that both HBsAg and HBcAg were found mainly in the cytoplasm of HPT-8-HBV cells, while they were mostly distributed in the nuclei of HepG2-HBV cells (Fig. 6C) .
Characterization of supernatant from HPT-8-HBV cells
We used PCR to amplify the unique pre-S sequences of HBV DNA in the supernatant from HPT-8-HBV and HepG2-HBV cells at passage 2 and showed that HBV was secreted into the culture medium of HPT-8-HBV and HepG2-HBV cells, but not parental HPT-8 cells (Fig. 7A) . Using ELISA, we demonstrated the presence of HBsAg and HBeAg in the culture medium of HPT-8-HBV and HepG2-HBV cells, but not in that of HPT-8 cells. However, the levels of HBsAg and HBeAg reduced dramatically after passage 4 in HPT-8-HBV cells (Fig. 7B and C) . We titrated the HBV viral particles in the culture supernatant of HPT-8-HBV cells and found a dramatic decrease in viral titer from 7.2 × 10 7 copies/l at 48 h after transfection to 4.81 × 10 6 copies/l and 2.73 × 10 6 copies/l at 1 month and 2 months post-transfection, respectively (Fig. 7D) . Although HepG2-HBV cells had the same viral titers as HPT-8-HBV cells (1.13 × 10 8 copies/l at 48 h after transfection), the titers decreased only slightly over a month following the transfection (5.17 × 10 7 copies/l after 1 month and 6.27 × 10 7 copies/l after 2 months) (Fig. 7D) . Each experiment was performed three times.
Discussion
In this study, we report the successful isolation of trophoblasts from Asian human first trimester placental chorionic villi. Spontaneously immortalized HPT-8 cells were derived from a single clone, maintained in culture and passaged more than 250 times. Since there are no reported cytotrophoblast cell lines expressing the adr subtype of HBV, we transfected HPT-8 cells with a construct carrying three head-to-tail copies of the adr subtype HBV full length DNA to produce the HBV-expressing clone of HPT-8. Chorionic villi are mainly composed of mesenchymal cells and trophoblasts. We used collagenase I to digest the mesenchymal cells to prevent their transformation to fibroblasts. Although most of the primary cultures died between the fifth and seventh passages, two samples were spontaneously immortalized and formed clones. Telomerase was recently reported to attenuate senescence and result in immortalization of trophoblasts (Wang et al., 2006a,b; StraszewskiChavez et al., 2009 ). It will be interesting to investigate if the spontaneous immortalization of trophoblasts seen in our study was the result of telomere shortening during replication.
Morphologic characterization of HPT-8 cells showed that most of the trophoblasts had a single nucleus, and 3-5% of the cells formed fuzed extravillous trophoblast cells (i.e. multinucleated giant cells) in each passage. Although the mechanism for this cell fusion is not clear, we suggest that it may represent cells undergoing in-vitro differentiation from cytotrophoblasts to syncytiotrophoblasts. The cells were flat and plane with a polygonal appearance, excluding the The abbreviations were: CK, cytokeratin 7; CK18, cytokeratin 18; CD9, cluster of differentiation antigen 9; hPL, human placental lactogen; SDF1, stromal cell-derived factor 1; PLAP, placental alkaline phosphatase; EGFR, epidermal growth factor receptor; HLA, human leukocyte antigen G. +++, very strong staining; ++, strong staining; +, weak staining; 2/+, very weak staining; 2, no staining.
possibility of contamination with fibroblasts. SEM and TEM analyses of HPT-8 cells demonstrated a large number of microvilli on the cell surface, distinct desmosomes between adjacent cells and an abundance of endoplasm, Golgi bodies, lipid inclusions and glycogen granules, which are all characteristic of trophoblasts (King et al., 2000) . Keratins, the skeleton proteins of epithelial cells, have been previously reported to be present in human placental cells, and CK7 has been used as a specific trophoblast marker Maldonado-Estrada et al., 2004) . CD9, another trophoblast marker, is a glycoprotein on the cell surface which is related to trophoblast cell migration and adhesion. The expression of both CK7 and CD9 constitute the minimum accepted requirements to characterize and validate an extravillous cytotrophoblast cell line (King et al., 2000) . In this study, we showed high levels of expression of both CK7 and CD9 in HPT-8 cells, strongly suggesting that HPT-8 cells are extravillous cytotrophoblasts. HPT-8 cells also contained CK18 and vimentin. Although expression of vimentin has been considered as a feature of non-trophoblastic cells (Manoussaka et al., 2005) , it is not unusual that the immortalized primary trophoblast cells co-express cytokeratin and vimentin: the F3 cells obtained by Hambruch et al. (2010) were continuously positive for zonula occludens-2 (ZO-2), cytokeratin and vimentin, and the Swan 71 cells isolated by Straszewski-Chavez et al. (2009) expressed CK7, vimentin and HLA-G. Trophoblasts are known to secrete hormones, such as hCG, hPL, prolactin, E 2 and progesterone, that all play a role in supporting normal gestation (Kurman et al., 1984; Henson et al., 1996) . Hormone characterization showed that although HPT-8 cells secreted prolactin, E 2 and progesterone, they secreted very low levels of hCG. This is likely because only 3-5% of the HPT-8 cells formed multinucleate giant cells. These data were also consistent with previous results showing that (i) expression levels of hCG, hCG-beta and hCG-alpha are significantly upregulated during the process of in vitro differentiation of cytotrophoblasts to syncytiotrophoblasts and (ii) hCG secretion in vivo is known to be confined to the villous syncytiotrophoblast, and not the mononuclear trophoblast cells (Kato and Braunstein, 1989) . Extravillous trophoblasts are characterized by high levels of prolactin and CD9. However, we found very low levels of hPL, which is a protein expressed in vivo in the extravillous trophoblasts, particularly in the endovascular trophoblast (Sheth et al., 1997; Kurman et al., 1984) . Although it has been reported that extravillous trophoblast cells in anchoring villi express negligible amounts of hPL, it would be interesting to understand the mechanism underlying the low levels of hPL in HPT-8 cells. We also showed that HPT-8 cells secreted EGFR, SDF1 and PLAP, which have been previously reported in human placental trophoblasts (Rettig et al., 1985; Wu et al., 2005) . EGFR, which is present in trophoblast cells from the blastocyst stage, is known to promote the differentiation of trophoblast cells into syncytiotrophoblast in vitro and may be involved in the regulation of fetal growth and development (Lai and Guyda, 1984) . Since HLA-G is accepted as the definitive marker of extravillous trophoblast cells, we used immunohistochemical staining and flow cytometry to characterize HPT-8 cells for the presence of HLA-G. Based on these data, HPT-8 cells were designated as extravillous trophoblast cells.
Infection of the fetus by vertical transmission of HBV is known to occur through the placental barrier Leikin et al., 1996) . Since trophoblast cells are the first layer of the placental barrier and are in direct contact with the maternal circulation, investigation of mechanisms underlying viral invasion of the feto-placental unit requires the successful isolation and infection of trophoblast cells.
A human cytotrophoblast cell culture obtained from 6 to 10 week placentas was previously shown to be highly sensitive to HBV infection in-vitro (Li et al., 2007) . We failed to obtain an HBV-expressing clone of HPT-8 when we infected HPT-8 cells with HBV positive serum (data not shown). Previous studies have suggested that expression of the intact viral genome requires transfection of more than a single copy of the genome (Lu et al., 1996) . We therefore used 3 head-to-tail copies of the adr subtype HBV full length DNA to transfect HPT-8 cells and showed the presence of secreted HBsAg and HBeAg in stably transformed HPT-8-HBV cells. The conversion of rcDNA to cccDNA, which is the template for the transcription of viral mRNAs (Tagawa et al., 1986) , suggested successful initiation of infection in our cell line. The pre-S1 protein is considered the hallmark of successful HBV infection (Ryu et al., 1997) . The presence of rcDNA, cccDNA and pre-S sequence in the HPT-8-HBV cells confirmed the creation of a stably transfected trophoblast cell line carrying the HBV genome.
HPT-8-HBV cells were immunopositive for HBsAg and HBeAg although HBV titers decreased markedly after a few passages, when compared with HepG2-HBV cells. This was consistent with the fact that HepG2 hepatoma cells are highly specific host cells, which are highly susceptible to HBV infection (Wang et al., 2006a; Sodunke et al., 2008) . HPT-8-HBV cells lost HBV DNA after passage 5 suggesting that only early passage cells can be used to study mechanisms of viral replication in these cells. Since the HBV genome was integrated into the genome of HPT-8-HBV cells, the mechanism of viral DNA replication differs distinctly from the natural infection process. This cell model can therefore not be used to study the adsorption, invasion and exuviation of HBV.
HPT-8 cells can be used for the in vitro study of viral diseases associated with pregnancy as well as other pregnancy-associated disorders, such as abortion and pre-eclampsia, which are associated with trophoblast dysfunction. The HBV pre-S1 protein, a surface antigen, plays a role in targeting the virus to host cells, in viral packaging and in the viral infection process, making HPT-8-HBV cells a useful tool to study these processes. We previously reported the role of placental tissue in intrauterine viral transfer (Xu et al., 2001 . Our future plans include co-culturing HPT-8-HBV cells which secrete active HBV virus with blood endothelial cells to study the transfer of HBV from trophoblasts to blood endothelial cells. We also aim to investigate the mechanisms underlying the spontaneous immortalization of our primary culture.
In summary, we developed an experimental model for studying HBV viral integration during intrauterine infection by establishing a spontaneously immortalized, villous cytotrophoblast cell line, HPT-8, and its HBV-expressing clone.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals. org/.
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